Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multidrug-Resistant Tuberculosis”

151 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 151 results

Not applicableStudy completedNCT03137875
What this trial is testing

Evaluation of PCR Using DNA Extract From Slides and Filter Paper for the Detection of Tuberculosis and MDR-tuberculosis

Who this might be right for
TuberculosisMulti Drug Resistant Tuberculosis
Epicentre 122
Early research (Phase 1)Study completedNCT01856634
What this trial is testing

Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis

Who this might be right for
Multidrug Resistant TuberculosisPediatric
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Post-approval studies (Phase 4)UnknownNCT04421495
What this trial is testing

Safety and Effectiveness of Delamanid-containing Regimen for MDR-TB Patients in China

Who this might be right for
Multidrug Resistant Tuberculosis
Beijing Chest Hospital 608
Not applicableEnded earlyNCT01381757
What this trial is testing

Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali

Who this might be right for
Tuberculosis, PulmonaryMycobacterium TuberculousAntitubercular Agents+3 more
National Institute of Allergy and Infectious Diseases (NIAID) 34
Large-scale testing (Phase 3)Looking for participantsNCT07209761
What this trial is testing

Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 532
Testing effectiveness (Phase 2)Study completedNCT03141060
What this trial is testing

Evaluating the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination With Optimized Multidrug Background Regimen (OBR) for Multidrug-Resistant Tuberculosis (MDR-TB) in HIV-Infected and HIV-Uninfected Children With MDR-TB

Who this might be right for
TuberculosisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 37
Testing effectiveness (Phase 2)Study completedNCT00425113
What this trial is testing

Metronidazole for Pulmonary Tuberculosis (South Korea)

Who this might be right for
TuberculosisMulti-Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 35
Large-scale testing (Phase 3)WithdrawnNCT02975570
What this trial is testing

Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin

Who this might be right for
Tuberculosis Multi Drug Resistant Active
Boston University
Large-scale testing (Phase 3)Study completedNCT02409290
What this trial is testing

The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB

Who this might be right for
MDR-TB
IUATLD, Inc 588
Not applicableUnknownNCT04484129
What this trial is testing

MDR-TB Close Contacts Tracing in China (TCCT Study)

Who this might be right for
Multidrug Resistant Tuberculosis
Huashan Hospital 500
Post-approval studies (Phase 4)Ended earlyNCT03237182
What this trial is testing

The Individualized M(X) Drug-resistant TB Treatment Strategy Study

Who this might be right for
Tuberculosis, Multidrug-Resistant
Centre for the AIDS Programme of Research in South Africa 205
Large-scale testing (Phase 3)Active Not RecruitingNCT06649721
What this trial is testing

Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese Cohort

Who this might be right for
Drug-resistant TuberculosisPulmonary TuberculosisRifampin-resistant Tuberculosis
Huashan Hospital 120
Early research (Phase 1)Study completedNCT05526911
What this trial is testing

A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults

Who this might be right for
Pulmonary DiseaseTuberculosis, PulmonaryTuberculosis+4 more
Global Alliance for TB Drug Development 28
Large-scale testing (Phase 3)Study completedNCT01424670
What this trial is testing

Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant Tuberculosis

Who this might be right for
Multidrug-resistant Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 511
Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Not applicableStudy completedNCT03942354
What this trial is testing

Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial

Who this might be right for
Multidrug Resistant Tuberculosis
Medecins Sans Frontieres, Netherlands 137
Early research (Phase 1)Study completedNCT02236078
What this trial is testing

Brief Bactericidal Activity of Anti-Tuberculosis Drugs

Who this might be right for
TuberculosisDrug-resistant TuberculosisIsoniazid Resistant Tuberculosis (Disorder)
Centers for Disease Control and Prevention 18
Not applicableUnknownNCT02496572
What this trial is testing

Effectiveness of a Simplified Short Regimen for Multidrug Resistant Tuberculosis in Uzbekistan

Who this might be right for
Multidrug Resistant Tuberculosis
Medecins Sans Frontieres, Netherlands 110
Not applicableStudy completedNCT00000796
What this trial is testing

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 525
Not applicableNot Yet RecruitingNCT06674291
What this trial is testing

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd. 222
Load More Results